health benefits of glp 1 agonists GLP-1 in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP−1 receptor agonists for the

[DOI] [PubMed] [Google Scholar] 212.Yang Y., Sharma R., Zimniak P., Awasthi Y.C

Because both NAC and glycine possess the unique ability to cross the blood-brain barrier, they are uniquely positioned as a therapeutic intervention to address this localized neurological deficiency

Side Effects and Safety Most common adverse effects include: Blue or green discoloration of urine and skin Nausea, vomiting, dizziness Confusion or serotonin syndrome (especially if combined with SSRIs) Hemolysis in patients with G6PD deficiency (contraindicated) It is generally well tolerated at low doses, but IV administration requires careful dosing due to risks of neurotoxicity and cardiac events at higher levels

Tanshinone IIA regulates NRF2/NLRP3 signal pathway to restrain oxidative stress and inflammation in uric acid-induced HK-2 fibrotic models